id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1445164,3b3d64e7-7e64-40cc-afcd-e78794345f22,Q3,KNIGHT CAPITOL CONSULTANTS,40036301,GENZYME CORPORATION,2013,third_quarter,TAX,"Possible changes in the tax code that affect the pharmaceutical industry, including the R&D tax credit and the Orphan Drug tax credit.","HOUSE OF REPRESENTATIVES,SENATE",40000,,0,0,2013-10-16T19:33:34.300000-04:00